Epigallocatechin gallate (EGCG) inhibits adhesion and migration of neural progenitor cells in vitro

Archives of Toxicology

Volumn 91, Issue 2, 2017, Pages 827-837

  Barenys, Marta ^a   Gassmann, Kathrin ^a   Baksmeier, Christine ^a   Heinz, Sabrina ^a   Reverte, Ingrid ^b   Schmuck, Martin ^a   Temme, Thomas ^a   Bendt, Farina ^a   Zschauer, Tim Christian ^a   Rockel, Thomas Dino ^a   Unfried, Klaus ^a   Wätjen, Wim ^c   Sundaram, Sivaraj Mohana ^a   Heuer, Heike ^a   Colomina, Maria Teresa ^b   Fritsche, Ellen ^a  

^a IUF LEIBNIZ RESEARCH INSTITUTE FOR ENVIRONMENTAL MEDICINE   (Germany)

^b UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Adhesion; DNT; Extracellular matrix; Food supplements; Migration; Neurospheres

Indexed keywords

BETA1 INTEGRIN; EPIGALLOCATECHIN GALLATE; CATECHIN; GLIAL FIBRILLARY ACIDIC PROTEIN; LAMININ; NES PROTEIN, HUMAN; NESTIN;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL COUNT; CELL DENSITY; CELL MIGRATION; CELL NUCLEUS; CONTROLLED STUDY; DIETARY SUPPLEMENT; EXTRACELLULAR MATRIX; GLIA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN SUBUNIT; RAT; ANALOGS AND DERIVATIVES; ANIMAL; CELL CULTURE; CELL MOTION; CYTOLOGY; DRUG EFFECTS; FEMALE; GENETICS; METABOLISM; PREGNANCY;

ANIMALS; ANTIGENS, CD29; CATECHIN; CELL ADHESION; CELL MOVEMENT; CELLS, CULTURED; DIETARY SUPPLEMENTS; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; LAMININ; NESTIN; NEURAL STEM CELLS; PREGNANCY; RATS;

EID: 85011636463     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-016-1709-8     Document Type: Article

References (56)

1. Abdel-Rahman A et al (2011) The safety and regulation of natural products used as foods and food ingredients. Toxicol Sci 123:333–348
2. Bal-Price A et al (2015) International STakeholder NETwork (ISTNET): creating a developmental neurotoxicity (DNT) testing road map for regulatory purposes. Arch Toxicol 89:269–287. doi:10.1007/s00204-015-1464-2
3. Barczyk M, Carracedo S, Gullberg D (2010) Integrins. Cell Tissue Res 339:269–280
4. Barenys M, Masjosthusmann S, Fritsche E (2015) Is intake of flavonoid-based food supplements during pregnancy safe for the developing child? A literature review. Curr Drug Targets [Epub ahead of print]
5. Baumann J, Barenys M, Gassmann K, Fritsche E (2014) Comparative human and rat “Neurosphere Assay” for developmental neurotoxicity testing. Curr Protoc Toxicol 59:12.21.1–12.21.24
6. Baumann J, Gassmann K, Masjosthusmann S, DeBoer D, Bendt F, Giersiefer S, Fritsche E (2015) Comparative human and rat neurospheres reveal species differences in chemical effects on neurodevelopmental key events. Arch Toxicol. doi:10.1007/s00204-015-1568-8
7. Baumann J, Dach K, Barenys M, Giersiefer S, Goniwiecha J, Lein PJ, Fritsche E (2016) Application of the neurosphere assay for DNT hazard assessment: challenges and limitations. Methods Pharmacol Toxicol. doi:10.1007/7653_2015_49
8. Belvindrah R, Graus-Porta D, Goebbels S, Nave K-A, Müller U (2007) β1 integrins in radial glia but not in migrating neurons are essential for the formation of cell layers in the cerebral cortex. J Neurosci 27:13854–13865
9. Bishop JL, Northstone K, Green J, Thompson EA (2011) The use of complementary and alternative medicine in pregnancy: data from the Avon Longitudinal Study of Parents and Children (ALSPAC). Complement Ther Med 19:303–310
10. Bracke ME et al (1987) The anti-invasive flavonoid (+)-catechin binds to laminin and abrogates the effect of laminin on cell morphology and adhesion. Exp Cell Res 173:193–205
11. Chen C-N, Liang C-M, Lai J-R, Tsai Y-J, Tsay J-S, Lin J-K (2003) Capillary electrophoretic determination of theanine, caffeine, and catechins in fresh tea leaves and oolong tea and their effects on rat neurosphere adhesion and migration. J Agric Food Chem 51:7495–7503
12. Chen Z-L, Haegeli V, Yu H, Strickland S (2009) Cortical deficiency of laminin γ1 impairs the AKT/GSK-3β signaling pathway and leads to defects in neurite outgrowth and neuronal migration. Dev Biol 327:158–168. doi:10.1016/j.ydbio.2008.12.006
13. Chu KO, Wang CC, Chu CY, Chan KP, Rogers MS, Choy KW, Pang CP (2006) Pharmacokinetic studies of green tea catechins in maternal plasma and fetuses in rats. J Pharm Sci 95:1372–1381
14. Clancy B, Finlay BL, Darlington RB, Anand K (2007) Extrapolating brain development from experimental species to humans. Neurotoxicology 28:931–937
15. Dorman DC et al (2001) Methods to identify and characterize developmental neurotoxicity for human health risk assessment. III: pharmacokinetic and pharmacodynamic considerations. Environ Health Perspect 109(Suppl 1):101–111
16. EFSAPPR (2013) Scientific Opinion on the developmental neurotoxicity potential of acetamiprid and imidacloprid. EFSA J 11:47. doi:10.2903/j.efsa.2013.3471
17. Ekor M (2013) The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol 4:177-1–177-10. doi:10.3389/fphar.2013.00177
18. Flanagan LA, Rebaza LM, Derzic S, Schwartz PH, Monuki ES (2006) Regulation of human neural precursor cells by laminin and integrins. J Neurosci Res 83:845–856
19. Forster DA, Denning A, Wills G, Bolger M, McCarthy E (2006) Herbal medicine use during pregnancy in a group of Australian women. BMC Pregnancy Childbirth 6:21
20. Fritsche E, Alm H, Baumann J, Geerts L, Håkansson H, Masjosthusmann S, Witters H (2015) Literature review on in vitro and alternative Developmental Neurotoxicity (DNT) testing methods EFSA supporting publication 2015 EN-778
21. Gassmann K et al (2010) Species-specific differential AhR expression protects human neural progenitor cells against developmental neurotoxicity of PAHs. Environ Health Perspect 118:1571–1577
22. Grandjean P, Landrigan PJ (2014) Neurobehavioural effects of developmental toxicity. Lancet Neurol 13:330–338
23. Graus-Porta D et al (2001) β1-class integrins regulate the development of laminae and folia in the cerebral and cerebellar cortex. Neuron 31:367–379
24. Hollman PC, Feskens EJ, Katan MB (1999) Tea flavonols in cardiovascular disease and cancer epidemiology. Proc Soc Exp Biol Med 220:198–202
25. Holmes G, McCabe B (2001) Brain development and generation of brain pathologies. Int Rev Neurobiol 45:17–41
26. Humphries JD, Byron A, Humphries MJ (2006) Integrin ligands at a glance. J Cell Sci 119:3901–3903
27. Hynes RO (2002) Integrins: bidirectional, allosteric signaling machines. Cell 110:673–687
28. Lee MJ et al (2002) Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol Biomark Prev 11:1025–1032
29. Leist M, Hartung T (2013) Inflammatory findings on species extrapolations: humans are definitely no 70-kg mice. Arch Toxicol 87:563–567
30. Lo HM, Hung CF, Huang YY, Wu WB (2007) Tea polyphenols inhibit rat vascular smooth muscle cell adhesion and migration on collagen and laminin via interference with cell-ECM interaction. J Biomed Sci 14:637–645. doi:10.1007/s11373-007-9170-6
31. Long L et al (2010) The preventive effect of oral EGCG in a fetal alcohol spectrum disorder mouse model. Alcohol Clin Exp Res 34:1929–1936. doi:10.1111/j.1530-0277.2010.01282.x
32. Manent JB, Beguin S, Ganay T, Represa A (2011) Cell-autonomous and cell-to-cell signalling events in normal and altered neuronal migration. Eur J Neurosci 34:1595–1608
33. Melgarejo E, Medina MA, Sanchez-Jimenez F, Urdiales JL (2009) Epigallocatechin gallate reduces human monocyte mobility and adhesion in vitro. Br J Pharmacol 158:1705–1712. doi:10.1111/j.1476-5381.2009.00452.x
34. Mineva ND, Paulson KE, Naber SP, Yee AS, Sonenshein GE (2013) Epigallocatechin-3-Gallate inhibits stem-like inflammatory breast cancer cells. PLoS ONE 8:e73464
35. Moors M, Cline JE, Abel J, Fritsche E (2007) ERK-dependent and-independent pathways trigger human neural progenitor cell migration. Toxicol Appl Pharmacol 221:57–67
36. Moors M et al (2009) Human neurospheres as three-dimensional cellular systems for developmental neurotoxicity testing. Environ Health Perspect 117:1131–1138
37. Moussally K, Oraichi D, Bérard A (2009) Herbal products use during pregnancy: prevalence and predictors. Pharmacoepidemiol Drug Saf 18:454–461
38. Navarro VJ, Barnhart H, Bonkovsky HL, Davern T, Fontana RJ, Grant L, Reddy KR, Seeff LB, Serrano J, Sherker AH, Stolz A, Talwalkar J, Vega M, Vuppalanchi R (2014) Liver injury from herbals and dietary supplements in the US drug-induced liver injury network. Hepatology 60(4):1399–1408. doi:10.1002/hep.27317
39. Nelson J, McFerran N, Pivato G, Chambers E, Doherty C, Steele D, Timson D (2008) The 67 kDa laminin receptor: structure, function and role in disease. Biosci Rep 28:33–48
40. Nordeng H, Havnen GC (2004) Use of herbal drugs in pregnancy: a survey among 400 Norwegian women. Pharmacoepidemiol Drug Saf 13:371–380
41. Park JH, Yoon JH, Kim SA, Ahn SG, Yoon JH (2010) (−)-Epigallocatechin-3-gallate inhibits invasion and migration of salivary gland adenocarcinoma cells. Oncol Rep 23:585–590
42. Rasband WS (1997-2013) ImageJ. Bethesda, MD, USA: U.S. National Institutes of Health. http://imagej.nih.gov/ij/
43. Rothwell JA et al (2013) Phenol-Explorer 3.0: a major update of the Phenol-Explorer database to incorporate data on the effects of food processing on polyphenol content. Database (Oxford) 2013
44. Schmid RS, Anton E (2003) Role of integrins in the development of the cerebral cortex. Cereb Cortex 13:219–224
45. Shanafelt TD et al (2009) Phase I trial of daily oral Polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia. J Clin Oncol 27:3808–3814
46. Shankar S, Ganapathy S, Hingorani SR, Srivastava RK (2008) EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer. Front Biosci 13:440–452
47. Singh B, Shankar S, Srivastava R (2011) Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem Pharmacol 82:1807–1821. doi:10.1016/j.bcp.2011.07.093
48. Soucy NV, Parkinson HD, Sochaski MA, Borghoff SJ (2006) Kinetics of genistein and its conjugated metabolites in pregnant Sprague-Dawley rats following single and repeated genistein administration. Toxicol Sci 90:230–240
49. Suganuma M, Okabe S, Oniyama M, Tada Y, Ito H, Fujiki H (1998) Wide distribution of [3H](−)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis 19:1771–1776
50. Suzuki Y, Isemura M (2001) Inhibitory effect of epigallocatechin gallate on adhesion of murine melanoma cells to laminin. Cancer Lett 173:15–20
51. Tiwari V, Kuhad A, Chopra K (2010) Epigallocatechin-3-gallate ameliorates alcohol-induced cognitive dysfunctions and apoptotic neurodegeneration in the developing rat brain. Int J Neuropsychopharmacol 13:1053–1066. doi:10.1017/s146114571000060x
52. Ullmann U et al (2003) A single ascending dose study of epigallocatechin gallate in healthy volunteers. J Int Med Res 31:88–101
53. Umeda D, Yano S, Yamada K, Tachibana H (2008) Green tea polyphenol epigallocatechin-3-gallate signaling pathway through 67-kDa laminin receptor. J Biol Chem 283:3050–3058
54. Wang J-S et al (2008) Validation of green tea polyphenol biomarkers in a phase II human intervention trial. Food Chem Toxicol 46:232–240
55. Yang C, Wang X, Lu G, Picinich S (2009) Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 9:429–439. doi:10.1038/nrc2641
56. Zini A et al (2006) Do flavan-3-ols from green tea reach the human brain? Nutr Neurosci 9:57–61